Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
proxy fight
MedTech
Altai Capital angles for OraSure board seats and a sale
The hedge fund published a letter to the company’s board, citing declines in OraSure’s stock price and the slowing of its core diagnostic sales.
Conor Hale
Mar 17, 2026 12:40pm
Cooper Companies under pressure to split—in different ways
Nov 20, 2025 1:47pm
OraSure sees investor pressure, potential proxy fight: report
Sep 9, 2025 12:00pm
Dynavax's feud with investor heats up ahead of annual meeting
May 12, 2025 7:15am
VC firm fights to end Dynavax's 'empire-building' strategy
Feb 19, 2025 2:22pm
Masimo names Politan nominee interim CEO after Joe Kiani's exit
Sep 25, 2024 11:00am
